Dr. Anushree Gulvady-Hayes focuses her work on patent drafting and prosecution with an emphasis on immunotherapy, genetics, genomics, and microbiology.
Prior to joining the firm, Anushree was a postdoctoral fellow at the Dana-Farber Cancer Institute, a principal affiliate of Harvard Medical University, where she conducted research for multiple immuno-oncology projects to identify novel metastatic signatures of breast cancer using cutting-edge transcriptomics, gene expression, CRISPR/Cas9 screens, immune profiling, and preclinical mouse models of breast cancer. She also collaborated on tumor evolution projects using targeted therapeutic strategies and high-complexity DNA barcoding techniques, resulting in a peer-reviewed publication. While she was a postdoctoral fellow, Anushree was also a business development fellow at the Office of Technology Development at Harvard University where she evaluated intellectual property landscapes, including prior art searches, patentability analysis, commercialization potential, and market research while developing successful commercialization strategies for cutting-edge Harvard technologies. She also drafted evolutionary maps of divisional/continuation patents for the patent team at the Wyss Institute at Harvard, and analyzed funding applications and drafted high-level progress reports for technologies, including therapeutics, immuno-modulatory drugs, anti-angiogenics, and antimicrobial peptide inhibitors for the Blavatnik Biomedical Accelerator at Harvard.
Anushree earned her Ph.D., with distinction, in anatomy and cell biology at the SUNY Upstate Medical University in Syracuse, New York. Her doctoral research focused on identifying novel signaling pathways required for cancer migration using advanced microscopy techniques that resulted in presentations at multiple scientific conferences.
Anushree received her M.S. and B.S. in microbiology from the University of Mumbai, India.Show More